CN113491739B - Pain-relieving and stasis-eliminating traditional Chinese medicine for treating endometriosis and preparation method thereof - Google Patents

Pain-relieving and stasis-eliminating traditional Chinese medicine for treating endometriosis and preparation method thereof Download PDF

Info

Publication number
CN113491739B
CN113491739B CN202110962414.2A CN202110962414A CN113491739B CN 113491739 B CN113491739 B CN 113491739B CN 202110962414 A CN202110962414 A CN 202110962414A CN 113491739 B CN113491739 B CN 113491739B
Authority
CN
China
Prior art keywords
parts
traditional chinese
chinese medicine
medicine
ginseng
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110962414.2A
Other languages
Chinese (zh)
Other versions
CN113491739A (en
Inventor
夏敏
刘恒炼
王彩霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Traditional Chinese Medicine Hospital
Original Assignee
Chongqing Traditional Chinese Medicine Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Traditional Chinese Medicine Hospital filed Critical Chongqing Traditional Chinese Medicine Hospital
Priority to CN202110962414.2A priority Critical patent/CN113491739B/en
Publication of CN113491739A publication Critical patent/CN113491739A/en
Application granted granted Critical
Publication of CN113491739B publication Critical patent/CN113491739B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/62Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282Artemisia, e.g. wormwood or sagebrush
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/66Papaveraceae (Poppy family), e.g. bloodroot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/89Cyperaceae (Sedge family)
    • A61K36/8905Cyperus (flatsedge)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an analgesic stagnation-removing traditional Chinese medicine for treating endometriosis and a preparation method thereof, belonging to the technical field of medicines, and the traditional Chinese medicine comprises the medicines of cooked rhubarb, leech, prepared nutgrass galingale rhizome, cassia twig, Chinese mugwort leaf, combined spicebush root, corydalis tuber and pseudo-ginseng; the medicine is prepared into capsules for taking; compared with the prior art, the traditional Chinese medicine composition has the beneficial effects that the traditional Chinese medicine composition can effectively treat pain, mass, menstrual disorder and infertility caused by endometriosis, and has obvious and definite curative effect and small side effect.

Description

Pain-relieving, mass-eliminating and stasis-removing traditional Chinese medicine for treating endometriosis and preparation method thereof
Technical Field
The invention relates to the technical field of medicines, in particular to a traditional Chinese medicine for treating endometriosis and relieving pain, eliminating mass and dissipating binds and a preparation method thereof.
Background
Endometriosis is a growing endometrial tissue, including glands and interstitium, that occurs in other parts of the body than the lining mucosa of the uterine cavity. The symptoms of dysmenorrheal, persistent abdominal pain, menstrual disorder, infertility, dyspareunia and the like are often caused, and due to the planting behavior, multiple organs of the whole body can be affected to form various nodules and masses, so that the serious pain affects sleeping, working and learning, the infertility can affect family stability, and the masses break, twist and even cause acute abdominal diseases. At present, most methods for treating endometriosis are operations, GnRH medicine injection, intrauterine device placement and the like, although the operations can solve the problem of mass formed by endometriosis, the curative effects on pain relieving and infertility are not ideal, and especially the effect on patients with unobvious focuses is not good enough; the injected GnRH medicine can play a role in inhibiting focus in a short time, but the disease relapse is more obvious after the treatment is stopped; the intrauterine device is suitable for patients with the fertility-free requirement; therefore, the above treatments have disadvantages and cannot be used for a long time for patients with fertility requirements. There are also a number of Chinese patent medicines in the market for relieving pain and eliminating mass, but no medicine specially aiming at endometriosis exists, and the curative effect on symptoms of endometriosis is poor.
In conclusion, the inventor provides the traditional Chinese medicine for treating endometriosis, relieving pain, eliminating symptoms and dissipating stagnation and the preparation method thereof.
Disclosure of Invention
The technical problem to be solved by the technical scheme of the invention is to treat the pain, mass, menstrual disorder and infertility of endometriosis, and in order to achieve the aim, the invention provides a traditional Chinese medicine for relieving pain, eliminating mass and dissipating stagnation and treating endometriosis and a preparation method thereof.
An analgesic stasis-removing traditional Chinese medicine for treating endometriosis comprises the following components in parts by weight: 8-10 parts of cooked rhubarb, 2-4 parts of leech, 5-7 parts of prepared rhizoma cyperi, 9-11 parts of cassia twig, 9-12 parts of folium artemisiae argyi, 9-11 parts of radix linderae, 14-17 parts of rhizoma corydalis and 5-7 parts of pseudo-ginseng; in the components of the invention, various medicinal materials have the following beneficial effects:
the cooked rhubarb mainly removes blood stasis, stops cold and heat, breaks illness, accumulates, remains food, washes intestines and stomach, promotes old to cause novelty, cools blood and detoxifies, promotes diuresis, regulates middle energizer and digests food, calms and harmonizes five internal organs; modern pharmacological research shows that the rhizome of rhubarb contains various bioactive components, and at least 25 elements exist in the inorganic component. Namely anthracene derivatives, stilbene compounds, tannins, organic acids, volatile oils and the like. Radix et rhizoma Rhei has effects of stopping bleeding, dispelling blood stasis, removing obstruction, promoting blood circulation, and dispelling blood stasis.
The leech can break blood, remove stasis and eliminate mass, and can be used for eliminating mass, and pharmacological research suggests that the leech contains heparin and antithrombotic agent and has an anticoagulation effect;
the rhizoma cyperi has the effects of soothing the liver, regulating the flow of qi, regulating menstruation and relieving pain, and pharmacological research can relieve the contraction force and tension of uterine smooth muscle; has inhibitory effect on Staphylococcus aureus and partial fungi.
Cassia twig has the functions of warming and dredging meridian and invigorating yang and regulating qi, and may be used in treating diseases, such as abdominal mass, arthralgia, etc. modern pharmacological research shows that it has several pathogenic bacteria inhibiting effect, tranquilizing, pain relieving and convulsion relieving effect.
Folium Artemisiae Argyi has effects of warming channels, warming uterus, stopping bleeding, dispelling cold, regulating menstruation, and inhibiting various pathogenic bacteria and fungi;
wu Yao warms kidney to dispel cold, promotes qi circulation to alleviate pain. Can be used for treating cold accumulation, qi stagnation, and pain, and has bidirectional regulating effect on smooth muscle.
Rhizoma corydalis has effects of promoting blood circulation, activating qi-flowing and relieving pain, is used for pain symptoms caused by qi and blood stasis, is used for treating various spastic and non-spastic pains of internal organs at present, and has effects of tranquilizing, hypnotizing and calming in pharmacological research.
Notoginseng radix has effects of promoting blood circulation, relieving pain, removing blood stasis and stopping bleeding, and can be used for treating pain due to blood stasis. Modern pharmacological research shows that the product has tranquilizing, analgesic, and anti-inflammatory effects, and also has antiaging and antitumor effects.
Further limited, the specific weight components of the medicine are as follows: 9 parts of cooked rhubarb, 3 parts of leech, 6 parts of prepared rhizoma cyperi, 10 parts of cassia twig, 10 parts of folium artemisiae argyi, 10 parts of radix linderae, 15 parts of rhizoma corydalis and 6 parts of pseudo-ginseng; the medicament of this ratio has better therapeutic effect.
Further limiting, mixing radix et rhizoma Rhei preparata, Hirudo, rhizoma Cyperi preparata, ramulus Cinnamomi, folium Artemisiae Argyi, radix Linderae, rhizoma corydalis and Notoginseng radix, and making into capsule for administration; the medicine is mixed to prepare the capsule, so that the taking effect is better, the medicine can be ensured not to be attached to the esophagus when being swallowed, and the treatment effect is improved.
Further limited, a preparation method of the traditional Chinese medicine formula for treating endometriosis with the functions of relieving pain and dissipating binds, which comprises the following steps:
001. firstly, performing sand scalding on leeches to prepare powder, then preparing pseudo-ginseng into powder, and respectively placing the powdered leeches and pseudo-ginseng aside for later use;
002. mixing radix et rhizoma Rhei preparata, rhizoma Cyperi preparata, ramulus Cinnamomi, folium Artemisiae Argyi, radix Linderae, and rhizoma corydalis, adding 10 times of clear water, decocting for 1 hr, and filtering to obtain medicinal liquid;
003. adding clear water with the weight 8 times of the total weight of the mixed medicines into the medicine dregs in the step 002, decocting for 1 hour, and filtering out liquid medicine for later use;
004. mixing the liquid medicines in the steps 002 and 003, and concentrating the obtained mixed liquid medicine into a thick paste for later use;
005. adding the leech powder and the pseudo-ginseng powder in the step 001 into the thick paste in the step 004, and stirring and mixing;
006. drying the thick paste completely mixed in the step 005, then crushing into powder, and filling into capsules.
Further limiting, the concentration in the step 004 can be realized by adopting modern mechanical concentration or slow boiling concentration with small fire; the concentration mode can be selected according to actual conditions.
Further limiting, the decocting in the steps 002 and 003 is firstly boiling with strong fire and then decocting with slow fire for 1 hour; the required effect can be achieved under the condition of ensuring the efficiency by firstly boiling with big fire and then decocting with small fire.
Compared with the prior art, the traditional Chinese medicine composition has the beneficial effects that the traditional Chinese medicine composition can effectively treat pain, mass, menstrual disorder and infertility caused by endometriosis, and has obvious and definite curative effect and small side effect.
Drawings
FIG. 1 is a symptom hierarchy table.
Detailed Description
In order that those skilled in the art can better understand the technical solution of the present invention, the following embodiments are further described with reference to the accompanying drawings and examples.
Example 1:
an analgesic and stasis-removing traditional Chinese medicine for treating endometriosis comprises the following components in parts by weight: 9 g of cooked rhubarb, 3 g of leech, 6 g of prepared nutgrass galingale rhizome, 10g of cassia twig, 10g of argy wormwood leaf, 10g of combined spicebush root, 15 g of corydalis tuber and 6 g of pseudo-ginseng;
a preparation method of an analgesic stasis-removing traditional Chinese medicine formula for treating endometriosis comprises the following preparation steps:
001. firstly, performing sand scalding on leeches to prepare powder, then preparing pseudo-ginseng into powder, and respectively placing the powdered leeches and pseudo-ginseng aside for later use;
002. mixing radix et rhizoma Rhei preparata, rhizoma Cyperi preparata, ramulus Cinnamomi, folium Artemisiae Argyi, radix Linderae, and rhizoma corydalis, adding 690 g of clear water, decocting for 1 hr, and filtering to obtain medicinal liquid;
003. adding 552 g of clear water of the total weight of the mixture of the medicines into the medicine dregs in the step 002, decocting for 1 hour, and filtering to obtain liquid medicine for later use;
004. mixing the liquid medicines in the steps 002 and 003, and then decocting the obtained mixed liquid medicine with slow fire for a long time to concentrate the mixed liquid medicine into thick paste for later use;
005. adding the leech powder and the pseudo-ginseng powder in the step 001 into the thick paste in the step 004, and stirring and mixing;
006. drying the thick paste completely mixed in the step 005, then crushing into powder, and encapsulating.
When the capsule is used by a patient, the prepared capsule is orally taken, each capsule is 0.5g, 4 capsules are taken each time, and the medicine is taken 3 times a day.
The main manifestations of the application of the technical proposal of the invention in treating dysmenorrheal, persistent hypogastric pain, menstrual disorder, infertility, dyspareunia and the like caused by endometriosis are 80 cases (including 40 cases of a control group), the curative effect and the side effect are considered, and the observed results are summarized as follows:
general clinical data:
80 cases of the group are all from outpatients of emergency department in hospital, 40 cases of the treatment group and the control group respectively,
treatment groups: 40 women, 14-49 years old (34.8 + -8.9), 9 mild, 22 moderate and 9 severe.
Control group: 40 women, 16-48 years old (36.4 + -10.2), 10 mild, 24 moderate and 6 severe.
According to the condition, the patients have catarrhal symptoms, which are mainly manifested as dysmenorrhea, persistent abdominal pain, menstrual disorder, infertility and dyspareunia.
Other medicines or externally applied medicines are not taken before treatment.
The diagnosis method comprises the following steps:
(1) disease diagnosis standard conditions: the traditional Chinese medicine diagnosis standard is as follows: refer to the Chinese medicine gynecological clinical research (Shuitangzhou Shuihu, edited by Xiao-Tuo, national institute of health and human, 2009) which is a research and development planning material in higher Chinese medical institutions in China. Western diagnostic criteria: refer to "clinical guide-gynecology and obstetrics brochure" (edited by the Chinese medical society, public health Press, 2009.)
(2) Disease diagnosis symptom grading:
physical signs: the uterus is usually in the posterior position, the activity is limited or the uterus is fixed by adhesion, and the uterus can have tenderness when the uterus is myositis; if the disease is salpingitis, the thick oviduct is touched on one side or two sides of the uterus and has tenderness; if the uterine tube hydrops or the uterine tube ovarian cyst is detected, cystic masses touch one side or two sides of the pelvic cavity, the movement is more limited, and the uterine tube hydrops or the uterine tube ovarian cyst can cause tenderness; in case of pelvic connective tissue inflammation, there is a thickening and tenderness of the slice on one or both sides of the uterus, or a thickening, stiffening and tenderness of the uterosacral ligaments.
Grading standard of disease condition degree
And (4) integrating the scores of the symptoms and the signs to judge the disease degree.
Mild: the score of symptoms and signs is 10-18.
Medium: symptoms, signs integration and 19-27 points.
And (2) the severity: the sum of the integral of symptoms and signs is more than or equal to 28 points.
(3) The medication method comprises the following steps:
the treatment group used the product of the invention, 0.5g per pill, 3 times a day, 4 pills each time. After the menstruation is cleared, the medicine is taken until the menstrual period stops. One menstrual cycle is a treatment course, three menstrual cycles are continuously treated, and contraception is performed during the treatment period. The control group orally takes the Dan e Fukang decoction ointment 10g each time and 3 times a day, and the Dan e Fukang decoction ointment is taken after cleaning until menstrual period stopping. One menstrual cycle is a treatment course, three menstrual cycles are continuously treated, and contraception is performed during the treatment period.
(4) The treatment course is as follows: the treatment group and the control group were administered for 3 months.
(5) The study controls variables and ensures that patients can only use the product of the invention and the contrast drug.
3. Determination of therapeutic effect
3.1 comprehensive therapeutic effect judgment standard: refer to the "clinical guiding principle of new Chinese medicine for treating endometriosis of pelvic cavity" and "clinical guiding principle of new Chinese medicine for treating dysmenorrhea" in the "clinical research guiding principle of new Chinese medicine".
The clinical cure is as follows: the pain symptoms all disappeared;
the effect is shown: the pain is obviously relieved, and the integral of the pain symptom is reduced by more than 1/2;
the method has the following advantages: the pain is relieved compared with that before treatment, but still obvious pain is felt, and the integral of the pain symptom is reduced by 1/4-1/2;
and (4) invalidation: pain did not change or worsen significantly before treatment, and the symptom score decreased less 1/4 or worsened.
3.2 the pain self-evaluation curative effect judgment standard of the patient: with reference to the world health organization: "visual analogue rating Scale for pain (VAS) oral rating Scale for pain (VRS)".
The clinical cure is as follows: the VAS and VRS integrals are both 0;
the effect is shown: the VAS and VRS integral is reduced by more than 1/2;
the method has the following advantages: the VAS and VRS integral is reduced by 1/4-1/2;
and (4) invalidation: the VAS, VRS integral reduction is under 1/4 or accentuated.
4. Results
The clinical efficacy of the two groups is compared as shown in the following table 2:
TABLE 2 therapeutic comparison
Grouping Number of cases Show effect Is effective Invalidation Total effective rate
Treatment group 40 14 22 4 90%
Control group 40 11 20 9 77.5%
There was no statistical difference in clinical efficacy between the treated group and the control group (p < 0.05).
5. Side effect observation:
the common side effects of the drugs are observed, and none of the treatment groups has side effects, while the incidence rate of the control group is 10 percent, and the statistical difference is generated (p is less than 0.05). The following table 3 is specific:
TABLE 3 comparison of adverse effects
Grouping Dizziness (lightheadedness) Diarrhea (diarrhea) Loss of appetite Rash of skin Incidence rate
Treatment group 0 1 0 1 5%
Control group 0 3 1 0 10%
The results show that: the product of the invention has better curative effect and less side effect on endometriosis compared with the traditional oral medicine.
Example 2:
the difference between the embodiment 2 and the embodiment 1 is that the weight of the medicine is 8 g of cooked rhubarb, 2 g of leech, 5g of prepared nutgrass galingale rhizome, 9 g of cassia twig, 9 g of Chinese mugwort leaf, 9 g of combined spicebush root, 14 g of corydalis tuber and 5g of sanchi; the weight of the clean water taken in the step 002 is 610 g, the weight of the clean water taken in the step 003 is 488 g, and the capsules with 0.5g of each capsule are prepared in the same way.
Example 3:
example 3 is different from example 1 only in that the weight of the medicine is 10g of cooked rhubarb, 4 g of leech, 7 g of prepared nutgrass galingale rhizome, 11 g of cassia twig, 12 g of Chinese mugwort leaf, 11 g of combined spicebush root, 17 g of corydalis tuber and 7 g of pseudo-ginseng; the weight of the clean water obtained in the step 002 is 790 g, and the weight of the clean water obtained in the step 003 is 632 g.
Compared with the prior art, the traditional Chinese medicine composition has the beneficial effects that the traditional Chinese medicine composition can effectively treat pain, mass, menstrual disorder and infertility caused by endometriosis, and has obvious and definite curative effect and small side effect.
The above description of the specific embodiments of the pain-relieving mass-dissipating traditional Chinese medicine for treating endometriosis and the preparation method thereof is only provided to help understanding the method and the core concept of the invention. It should be noted that, for those skilled in the art, it is possible to make various improvements and modifications to the present invention without departing from the principle of the present invention, and those improvements and modifications also fall within the scope of the claims of the present invention.

Claims (4)

1. The traditional Chinese medicine for treating endometriosis is characterized by comprising the following components in parts by weight: 8-10 parts of cooked rhubarb, 2-4 parts of leech, 5-7 parts of prepared rhizoma cyperi, 9-11 parts of cassia twig, 9-12 parts of folium artemisiae argyi, 9-11 parts of radix linderae, 14-17 parts of rhizoma corydalis and 5-7 parts of pseudo-ginseng.
2. The traditional Chinese medicine for treating endometriosis according to claim 1, wherein: the weight components of the medicine are as follows: 9 parts of cooked rhubarb, 3 parts of leech, 6 parts of prepared rhizoma cyperi, 10 parts of cassia twig, 10 parts of folium artemisiae argyi, 10 parts of radix linderae, 15 parts of rhizoma corydalis and 6 parts of pseudo-ginseng.
3. The method for preparing a traditional Chinese medicine for treating endometriosis according to claim 1, wherein the method comprises the following steps: the method comprises the following steps:
001. firstly, performing sand scalding on leeches to prepare powder, then preparing pseudo-ginseng into powder, and respectively placing the powdered leeches and pseudo-ginseng aside for later use;
002. mixing radix et rhizoma Rhei preparata, rhizoma Cyperi preparata, ramulus Cinnamomi, folium Artemisiae Argyi, radix Linderae, and rhizoma corydalis, adding 10 times of clear water, decocting for 1 hr, and filtering to obtain medicinal liquid;
003. adding clear water with the weight 8 times of the total weight of the mixed medicine into the medicine dregs in the step 002, decocting for 1 hour, and filtering to obtain liquid medicine for later use;
004. mixing the liquid medicines in the steps 002 and 003, and concentrating the obtained mixed liquid medicine into a thick paste for later use;
005. adding the leech powder and the pseudo-ginseng powder in the step 001 into the thick paste in the step 004, and stirring and mixing;
006. drying the thick paste completely mixed in the step 005, then crushing into powder, and filling into capsules.
4. The method for preparing a traditional Chinese medicine for treating endometriosis according to claim 3, wherein: the decocting in the steps 002 and 003 is carried out by boiling with strong fire and then decocting with slow fire for 1 hour.
CN202110962414.2A 2021-08-20 2021-08-20 Pain-relieving and stasis-eliminating traditional Chinese medicine for treating endometriosis and preparation method thereof Active CN113491739B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110962414.2A CN113491739B (en) 2021-08-20 2021-08-20 Pain-relieving and stasis-eliminating traditional Chinese medicine for treating endometriosis and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110962414.2A CN113491739B (en) 2021-08-20 2021-08-20 Pain-relieving and stasis-eliminating traditional Chinese medicine for treating endometriosis and preparation method thereof

Publications (2)

Publication Number Publication Date
CN113491739A CN113491739A (en) 2021-10-12
CN113491739B true CN113491739B (en) 2022-09-13

Family

ID=77995953

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110962414.2A Active CN113491739B (en) 2021-08-20 2021-08-20 Pain-relieving and stasis-eliminating traditional Chinese medicine for treating endometriosis and preparation method thereof

Country Status (1)

Country Link
CN (1) CN113491739B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1081107A (en) * 1992-03-16 1994-01-26 山东青岛中西医结合医院 Medicine for endometriosis and manufacturing process thereof
CN107375837A (en) * 2017-08-01 2017-11-24 大连大学 It is a kind of to be used to treat Chinese medicine compound prescription of endometriosis and preparation method thereof
CN109381678A (en) * 2017-08-07 2019-02-26 登封市通达科技有限公司 The syrup for preventing and treating vital energy stagnation and blood stasis type endometriosis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1081107A (en) * 1992-03-16 1994-01-26 山东青岛中西医结合医院 Medicine for endometriosis and manufacturing process thereof
CN107375837A (en) * 2017-08-01 2017-11-24 大连大学 It is a kind of to be used to treat Chinese medicine compound prescription of endometriosis and preparation method thereof
CN109381678A (en) * 2017-08-07 2019-02-26 登封市通达科技有限公司 The syrup for preventing and treating vital energy stagnation and blood stasis type endometriosis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
中西医结合治疗子宫内膜异位免疫性不孕的可行性;胡盛书;《中国现代药物应用》;20130710;第7卷(第13期);39-40 *
散结镇痛胶囊与经舒颗粒治疗轻度子宫内膜异位症临床研究;玲娟等;《世界中西医结合杂志》;20150929;第10卷(第09期);1290-1292 *

Also Published As

Publication number Publication date
CN113491739A (en) 2021-10-12

Similar Documents

Publication Publication Date Title
CN1061854C (en) Medicinal preparation for treatment and prevention of gynopathy
CN101983644A (en) Medicament for treating sequelae of apoplexy
CN113491739B (en) Pain-relieving and stasis-eliminating traditional Chinese medicine for treating endometriosis and preparation method thereof
CN104689132A (en) Traditional Chinese medicine composition for treating psoriasis
CN101181344B (en) Chinese medicine medicament for curing renal calculs
CN103705632A (en) Application of mammary aggregation dispersing tablets in preparation of medicines for treating penis hardening disease
CN103585315A (en) Traditional Chinese medicinal preparation for treating deep venous thrombosis of lower limbs
CN103611027B (en) The pharmaceutical composition of a kind of clinical prevention, nursing and treatment trichomonal vaginitis
CN108619427B (en) Pain-relieving and acid-reducing herb tea for preventing and treating gouty arthritis
CN102614324A (en) Chinese medicinal synthetic preparation for assisting western medicines in treating phlebophlogosis
CN102205096A (en) Medicament for treating adnexitis and pelvic inflammation
CN102488832B (en) Traditional Chinese medicine composition for treating mastitis
CN101961455A (en) Traditional Chinese medicine for treating chronic colitis disease
CN104815092A (en) Traditional Chinese medicine composition for treating chronic pelvic inflammation
CN110420305B (en) Traditional Chinese medicine composition for treating chronic muscle injuries and preparation method thereof
CN103520638B (en) A kind of Traditional Chinese medicine compound composition for the treatment of prostate hyperplasia and preparation method thereof and application thereof
NL2031436B1 (en) Hemorrhoid and fistula mixture
CN111905002B (en) Traditional Chinese medicine preparation for treating sequelae of pelvic inflammatory disease and preparation method and application thereof
CN116474058B (en) Traditional Chinese medicine ointment for treating spleen enlargement
CN113244363B (en) Traditional Chinese medicine cake moxibustion for orthopedics department as well as preparation method and application thereof
CN101954043A (en) Medicament for treating hyperosteogeny and preparation method thereof
CN105770753A (en) Traditional Chinese medicine composition for treating extrauterine pregnancy
CN104666824A (en) Traditional Chinese medicinal composition for treating psoriasis
CN104758346A (en) Medicine for treating migraine, as well as preparation method and preparation of medicine
CN104689254A (en) Traditional Chinese medicine composition for treating psoriasis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant